Research co-led by University of Toronto researchers and Insilico Medicine has demonstrated the potential of quantum ...

UC Santa Cruz has announced the Innovation Catalyst Grant proof-of-concept program awardees, showcasing the campus’s ...

ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, ...

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

The author of the seminal cancer biography The Emperor Of All Maladies and the co-founder of LinkedIn are looking to connect ...

The LinkedIn co-founder is starting Manas AI with “The Emperor of All Maladies” author Siddhartha Mukherjee.

This piece is part of a series that dives deeper into the most prevalent themes of this year’s iteration of our flagship research piece, Charting Disruption. Click to read.

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy.

AI models are able to design molecules that don’t even exist in nature. Some have proven effective as snake antivenom.

Collaborative project with world leader in AI computing demonstrates Artificial workflows and model integration for self-driving generative virtual screening in drug discovery. Company also announces ...